These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31275324)

  • 1. Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris.
    Di Lullo G; Calabresi V; Mariotti F; Zambruno G; Lanzavecchia A; Di Zenzo G
    Front Immunol; 2019; 10():1391. PubMed ID: 31275324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
    Femiano F
    Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris.
    Chen Y; Chernyavsky A; Webber RJ; Grando SA; Wang PH
    J Biol Chem; 2015 Sep; 290(39):23826-37. PubMed ID: 26260795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The location of binding sites of pemphigus vulgaris and pemphigus foliaceus autoantibodies: a post-embedding immunoelectron microscopic study.
    Zhou S; Ferguson DJ; Allen J; Wojnarowska F
    Br J Dermatol; 1997 Jun; 136(6):878-83. PubMed ID: 9217820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoglein autoimmunity in the pathogenesis of pemphigus.
    Gniadecki R
    Autoimmunity; 2006 Nov; 39(7):541-7. PubMed ID: 17101497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response in pemphigus and beyond: progresses and emerging concepts.
    Di Zenzo G; Amber KT; Sayar BS; Müller EJ; Borradori L
    Semin Immunopathol; 2016 Jan; 38(1):57-74. PubMed ID: 26597100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigus vulgaris antibody identifies pemphaxin. A novel keratinocyte annexin-like molecule binding acetylcholine.
    Nguyen VT; Ndoye A; Grando SA
    J Biol Chem; 2000 Sep; 275(38):29466-76. PubMed ID: 10899159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.
    Heupel WM; Zillikens D; Drenckhahn D; Waschke J
    J Immunol; 2008 Aug; 181(3):1825-34. PubMed ID: 18641320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear magnetic resonance titration of the interaction between pemphigus vulgaris autoantibodies and REWVKFAKPCRE, a therapeutic desmoglein 3 peptide.
    Lucchese A; Sinha AA
    Clin Exp Dermatol; 2016 Aug; 41(6):585-90. PubMed ID: 26936204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplexed autoantigen microarrays identify HLA as a key driver of anti-desmoglein and -non-desmoglein reactivities in pemphigus.
    Sajda T; Hazelton J; Patel M; Seiffert-Sinha K; Steinman L; Robinson W; Haab BB; Sinha AA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1859-64. PubMed ID: 26831096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris.
    Ishii K; Harada R; Matsuo I; Shirakata Y; Hashimoto K; Amagai M
    J Invest Dermatol; 2005 May; 124(5):939-46. PubMed ID: 15854034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity and clinical expression in pemphigus vulgaris.
    Naseer SY; Seiffert-Sinha K; Sinha AA
    Autoimmunity; 2015 Jun; 48(4):231-41. PubMed ID: 25384535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles.
    Ding X; Aoki V; Mascaro JM; Lopez-Swiderski A; Diaz LA; Fairley JA
    J Invest Dermatol; 1997 Oct; 109(4):592-6. PubMed ID: 9326396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoglein-3 is a target autoantigen in spontaneous canine pemphigus vulgaris.
    Olivry T; Joubeh S; Dunston SM; Nishiyama T; Ghohestani RF
    Exp Dermatol; 2003 Apr; 12(2):198-203. PubMed ID: 12702149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor.
    Heupel WM; Engerer P; Schmidt E; Waschke J
    Am J Pathol; 2009 Feb; 174(2):475-85. PubMed ID: 19147829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemphigus vulgaris and its active disease mouse model.
    Amagai M
    Curr Dir Autoimmun; 2008; 10():167-81. PubMed ID: 18460885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.